Article
Molecular design for recombinant adeno-associated virus (rAAV) vector production
4 Dec 2017
Abstract excerpt
Recombinant adeno-associated virus (rAAV) vectors are increasingly popular tools for gene therapy applications. Their non-pathogenic status, low inflammatory potential, availability of viral serotypes with different tissue tropisms, and prospective long-lasting gene expression are important attributes that make rAAVs safe and efficient therapeutic options. Over the last three decades, several groups have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
